• opioid Sep 14

    Narcan Explained: What Is It and How Do You Use It?

    Ninety-one people in the U.S. die every day from opioid-related overdoses, but there’s a tool that can reverse the effects of an overdose that more and more law enforcement agencies and paramedics are now carrying with them as part of their standing operating protocol. It’s called Narcan, and here is what you need to know about what it is, how...

  • New York Oct 6, 2019

    Victims, Families Gain Key Role in Purdue Bankruptcy Case

    Victims of opioid addiction weren’t in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company’s role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by addiction have important seats at the table — and could force fundamental changes to...

  • New York Oct 5, 2019

    Purdue Opioid Deal Blasted as Records Show $13B to Sacklers

    Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of Purdue Pharma’s offer to settle thousands of lawsuits over the nation’s opioid crisis in court filings that also said the company had funneled up to $13 billion to its controlling family. Their legal filings said the tentative deal does...

  • Florida Sep 18, 2019

    6 Things to Know – Sweatshirt Controversy, Expensive Wig Heist

    It’s Wednesday, September 18th – and NBC 6 has the top stories you need to know for the day.

  • Florida Sep 18, 2019

    ‘They're Drug Dealers': South Florida Mother Disappointed Over Opioid Settlement

    Lawsuits against the company alleged Purdue aggressively sold Oxycontin as a drug with low risk of addiction, although it knew that wasn’t true. A potential 12 billion dollar settlement would resolve thousands of lawsuits. But, several states – and Dodds- oppose it.

  • United States Sep 11, 2019

    OxyContin Maker Agrees to Tentative Settlement: Attorneys

    Attorneys for some 2,000 local governments say they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation’s opioid crisis.

  • New York Sep 9, 2019

    Purdue Pharma Says Settlement Talks in Opioid Cases Not Over

    OxyContin maker Purdue Pharma and lawyers representing local governments both said Sunday that they’re interested in continuing negotiations to settle lawsuits over the toll of the opioid crisis a day after two state attorneys general told colleagues that their talks with the company were at an impasse and that they expected the company to file imminently for bankruptcy. The statements...

  • Connecticut Sep 3, 2019

    Purdue University: School Has No Connection to Purdue Pharma

    Purdue University in Indiana wants the public to know that it has no connection to a Connecticut-based company blamed for helping drive the nation’s opioid crisis.

  • judge Aug 2, 2019

    Purdue Pharma Must Be ‘Held Accountable,' Families Say

    They came bearing oversized images of the sons and daughters they lost to drug overdoses and signs demanding justice from the pharmaceutical company they hold most responsible. The parents and their supporters rallied outside a Boston courthouse Friday as a judge heard arguments in Massachusetts’ lawsuit against Purdue Pharma, the maker of OxyContin, over its role in the national opioid...

  • United States Jul 24, 2019

    No Obligation to the Public, Opioid Distributor Tells Lawyer

    An executive at one of the nation’s largest drug distribution companies said under questioning recently that the business has no obligation to the public when it comes to the amount of prescription opioid painkillers it ships. That’s one of the exchanges included in thousands of pages of court documents, including depositions and internal emails, made public this week in lawsuits...

  • United States Jun 20, 2019

    UN Health Agency to Remove Controversial Opioid Guidelines

    The World Health Organization notified U.S. lawmakers Wednesday that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue Pharma, the American manufacturer of the...

  • United States Jun 20, 2019

    UN Health Agency to Remove Controversial Opioid Guidelines

    The World Health Organization notified U.S. lawmakers Wednesday that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue Pharma, the American manufacturer of the...

  • President Jun 3, 2019

    California Sues Opioid Maker Purdue Pharma

    California on Monday became the latest state to sue the pharmaceutical company behind the painkiller OxyContin, alleging it falsely promoted the drug as not addictive even as it emerged as one of the most widely abused in the U.S.

  • President Jun 3, 2019

    California Sues Opioid Maker Purdue Pharma

    California on Monday became the latest state to sue the pharmaceutical company behind the painkiller OxyContin, alleging it falsely promoted the drug as not addictive even as it emerged as one of the most widely abused in the U.S.

  • Facebook Apr 12, 2019

    Parents Press Harvard to Remove Opioid Maker's Name From Museum

    Parents whose children fatally overdosed on opioids are demanding Harvard University remove the name of a family whose company makes the powerful painkiller OxyContin from a building that housed one of its art museums. About two dozen parents protested Friday outside the building the housed the Arthur M. Sackler Museum.

  • NBC Mar 5, 2019

    OxyContin Maker Purdue Pharma Exploring Bankruptcy: Source

    OxyContin maker Purdue Pharma is exploring filing for bankruptcy as one of its options to address potentially significant liabilities from thousands of lawsuits alleging the drug maker contributed to the deadly opioid crisis sweeping the U.S., NBC News confirmed through a source familiar with the matter. The deliberations show how Purdue and its wealthy owners, the Sackler family, are under...

  • NBC Jan 4, 2019

    Taco Bell Employee Fired After Video Shows Man Believed to Be Deaf Denied Service

    After video showed a man believed to be deaf being denied service while trying to use a cellphone to order at an Ohio Taco Bell drive-thru, the company said the employee involved was fired, NBC News reported. The video was posted to Facebook by a woman who said she was the man’s mother. A worker is heard telling the man,...

  • Donald Trump Nov 19, 2018

    Florida Sues Walgreens, CVS Over Opioid Sales

    Attorney General Pam Bondi announced late Friday that she has added the companies to a state-court lawsuit filed last spring against Purdue Pharma, the maker of OxyContin, and several opioid distributors.

  • crime Sep 25, 2018

    Feds' New Tool to Combat Opioid Crisis: Data

    Federal officials have a new tool to battle the opioid crisis: data. The Office of National Drug Control Policy’s “High Intensity Drug Trafficking Area” program is using a web portal called the “OD Map” to track overdoses caused by opioids in real time. The program will help the agency target high-problem areas with resources and track the sources of...

  • judge Sep 5, 2018

    Major Opioid Maker Purdue Pharma to Pay for Overdose-Antidote Development

    A company whose prescription opioid marketing practices are being blamed for sparking the addiction and overdose crisis says it’s helping to fund an effort to make a lower-cost overdose antidote. OxyContin maker Purdue Pharma announced Wednesday that it’s making a $3.4 million grant to Harm Reduction Therapeutics, a Pittsburgh-based nonprofit, to help develop a low-cost naloxone nasal spray. The announcement...

Contact Us